Latest pharma updates on FDA Approval
Weekly Pharma Update – 15th to 27th December 2025
1) FDA Approves Lunsumio VELO™ for Subcutaneous Use in Follicular Lymphoma Date: 22 December 2025 What’s...
Read Full StoryWeekly Pharma Update — 8 to 13 December 2025
1) FDA Approves DAYBUE® STIX for Rett Syndrome (12 Dec 2025) What’s new: The U.S. FDA has given the green l...
Read Full Story